MEETINGS - Molecular Diagnostics: Towards Targeted Therapeutics (US) May 2003:
This article was originally published in Clinica
Executive Summary
Molecular Diagnostics: Towards Targeted Therapeutics will take place on May 28-30 2003 at the Seaport Hotel, Boston, Massachusetts. The conference will focus on technologies and advancements in understanding the molecular basis of diseases. It will also cover practical issues such as reimbursement. Further details from IBC Conferences, on tel: +1 508 616 5550; fax: +1 508 616 5522; email: [email protected]
You may also be interested in...
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.